Otonomy Inc. (OTIC) Soars 5.56% on January 04

Otonomy Inc. (OTIC) Soars 5.56% on January 04

Otonomy Inc. (OTIC) had a good day on the market for Friday January 04 as shares jumped 5.56% to close at $1.90. About 106,954 shares traded hands on 635 trades for the day, compared with an average daily volume of n/a shares out of a total float of 30.63 million. After opening the trading day at $1.82, shares of Otonomy Inc. stayed within a range of $1.94 to $1.82.

With today’s gains, Otonomy Inc. now has a market cap of $58.2 million. Shares of Otonomy Inc. have been trading within a range of $6.45 and $1.50 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone for the treatment of Meniere’s disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation for the treatment of tinnitus. All the business activity is primarily operates through the region of United States.

Otonomy Inc. is based out of San Diego, CA and has some 53 employees. Its CEO is David A. Weber.

error: Content is protected !!